Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy - Wikidata - wikimedia - TriplyDB

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

http://www.wikidata.org/entity/Q57181194

about

Viral and latent reservoir persistence in HIV-1-infected patients on therapy Renal function in Ghanaian HIV-infected patients on highly active antiretroviral therapy: a case-control study Markov Chain Modelling Analysis of HIV/AIDS Progression: A Race-based Forecast in the United States.Time to immunologic recovery and determinant factors among adults who initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia.Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.Risk of deaths, AIDS-defining and non-AIDS defining events among Ghanaians on long-term combination antiretroviral therapy.The effect of adherence to guidelines for initial antiretroviral therapy on 1-year outcomes: a French cohort study Prediction based classification for longitudinal biomarkers.Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression.Among patients with sustained viral suppression in a resource-limited setting, CD4 gains are continuous although gender-based differences occur.CD4 cell count trends after commencement of antiretroviral therapy among HIV-infected patients in Tigray, Northern Ethiopia: a retrospective cross-sectional study.Hepatic Enzyme Alterations in HIV Patients on Antiretroviral Therapy: A Case-Control Study in a Hospital Setting in Ghana Pattern and predictors of immunologic recovery in HIV infected patients.HIV RNA suppression and immune restoration: can we do better?Predictors of CD4 count over time among HIV patients initiated ART in Felege Hiwot Referral Hospital, northwest Ethiopia: multilevel analysis.Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.Joint longitudinal data analysis in detecting determinants of CD4 cell count change and adherence to highly active antiretroviral therapy at Felege Hiwot Teaching and Specialized Hospital, North-west Ethiopia (Amhara Region).Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003-2013: TREAT Asia HIV Observational Database Low Intensity Transfer.Ageing and long-term CD4 cell count trends in HIV-positive patients with 5 years or more combination antiretroviral therapy experience Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases The interplay between CD4 cell count, viral load suppression and duration of antiretroviral therapy on mortality in a resource-limited setting.Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients.Nutritional status and its effect on treatment outcome among HIV infected clients receiving HAART in Ethiopia: a cohort study Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care.Long-term patterns in CD4 response are determined by an interaction between baseline CD4 cell count, viral load, and time: The Asia Pacific HIV Observational Database (APHOD)Quasi-Poisson versus negative binomial regression models in identifying factors affecting initial CD4 cell count change due to antiretroviral therapy administered to HIV-positive adults in North-West Ethiopia (Amhara region).Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.Blunted response to combination antiretroviral therapy in HIV elite controllers: an international HIV controller collaboration The immunological response of HIV-positive patients initiating HAART at the Komfo Anokye Teaching Hospital, Kumasi, Ghana Retention in HIV Care and Viral Suppression: Individual- and Neighborhood-Level Predictors of Racial/Ethnic Differences, Florida, 2015.Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.[Factors associated with immunovirologic dissociation in HIV-1-infected patients under highly active antiretroviral therapy in the Ambulatory Treatment Center (ATC) in Dakar].Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients.Remission of human immunodeficiency virus-related lymphoma in association with immune reconstitution on anti-retroviral therapy, without chemotherapy.Cost effectiveness of darunavir/ritonavir in highly treatment-experienced, HIV-1-infected adults in the USA.Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs.

P2860

Q28469057-7508C32E-8017-4857-A801-F60A77ED3060 Q28539647-400D3D8E-23CE-41BA-9A8C-EE9EBC6D4E95 Q30362726-55C779AD-09A6-4EE7-9660-1319C510F3EB Q33909241-843C0965-194C-42EA-8B82-A8FC8C93C63E Q33933071-5E834852-ACFA-4E0B-BD6A-71BF7B0EB1D7 Q34100187-5ACD746F-0F2C-43BA-A79E-BF5F5DB15393 Q34395892-B267BF5B-C088-44FB-BF0D-913DA68ADD44 Q34517842-4C615AFE-4D4F-4F75-B0FF-35E714F6D4AC Q34518252-DB0FDEA7-0D2D-4A0A-9F40-9964F30C671A Q34546011-32DF121C-A9B8-40E8-A1AA-C83E15A7C236 Q34981015-8DCB14CA-6131-4E74-8862-52125A2E5CA4 Q35225198-FAF0B2F1-A51C-4D02-B1B4-374E342569F5 Q35738818-3523E1A0-283D-4A84-9FA9-A6CC7CA96D4A Q35765115-EAF4B4D1-0401-4DEE-9206-CDEC0C1D5ACB Q35867173-87C33E19-1C56-460F-90A8-B30526085DF4 Q36091039-B817EBB4-CBAD-4F4C-A41A-D81F52DABA83 Q36187496-0B274C91-5897-4712-BE02-4AE60BC31723 Q36311314-421533A7-0914-4B4B-B633-B29F1BB11DAF Q36410265-FB305EF4-6DFF-4F7F-BF9E-6DD2CD3B1595 Q36565914-BC011557-F54E-49C0-BC48-AA0392FEA539 Q36743092-9E464B3D-CC63-4982-827F-A6F1A220ED35 Q36763062-9DEFC5D4-EFF8-4D95-8C34-1390CCB0E103 Q36943004-91AAC94B-B785-4A7E-A6D3-F5BB0C1D598B Q37278636-A8447ADC-DE40-458E-87C2-52E35FBBD40D Q37305191-575FBE81-45F8-46F4-B712-B5A81B013368 Q37364321-F9ED5C35-A54E-4A27-9C71-C2B79437701C Q37406148-9869EAA5-6ECA-4919-986C-F603F037787F Q37477423-ABFF77BF-829A-4E0F-B775-9FC077F9C378 Q37490654-6717344C-32F4-441D-A029-195F2FD0537B Q37653953-E1840A6D-E80E-445C-8A00-AAEF6AA3A68A Q38834638-E873D36B-B49C-498B-82D9-5B25AB8AFB0A Q38917930-5584FCE6-BD6D-46A9-9C17-3085508F4E59 Q40106808-FB17A50E-F344-4171-B06E-7BB597BD972E Q40763955-394A8CB5-863A-4B1B-8760-8F6AAEDFD2EE Q40927354-D366CCA2-A793-4C12-9AB8-CA747DBB1314 Q42772440-3F505C1C-81AB-42B8-A304-1807DD62D167 Q42924252-113FE643-D242-45E4-955F-71CE7801AE2D Q43282852-AFA3AD60-9ED1-4F5B-9498-6B66DCC93EB8 Q44256226-1F045A73-6CA4-4F42-9807-4D2C7515FEDD Q44566864-B25B907B-17FD-4609-89EC-10693A45F8AE

P2860

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

http://www.wikidata.org/entity/Q57181194

description

article

@en

im Oktober 2004 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в листопаді 2004

@uk

name

Factors Influencing Increases ...... Active Antiretroviral Therapy

@en

Factors Influencing Increases ...... Active Antiretroviral Therapy

@nl

type

label

Factors Influencing Increases ...... Active Antiretroviral Therapy

@en

Factors Influencing Increases ...... Active Antiretroviral Therapy

@nl

prefLabel

Factors Influencing Increases ...... Active Antiretroviral Therapy

@en

Factors Influencing Increases ...... Active Antiretroviral Therapy

@nl

P1433

Q57181194-BB82DADA-CD37-4195-905B-6AA0FD22D660

P1476

Q57181194-2AFFB31E-CB7F-4AA2-9B0A-BF6E393C730A

P2093

Q57181194-1F2B41AA-BCAB-41DB-B16D-7850779E666E

Q57181194-3CE1793C-77C9-41D2-8F58-6612F36265D3

Q57181194-41E037A2-F75C-4E08-8867-4BBC4D2857DC

Q57181194-8769D860-5273-4FE8-A802-1DC900C2284A

Q57181194-B40DB37E-2308-4826-AD80-5FB02940B32C

Q57181194-CD618E16-B45E-4830-857B-ACF3CFB4A930

Q57181194-D3AB8EBC-0F63-4FB8-9134-8A3AB39B672E

Q57181194-FF4DDA51-CF1C-4C90-B5BA-81D68E1F07D6

P304

Q57181194-C23C6991-B9BE-4053-93C0-9E3726CF2594

P31

Q57181194-C8DFC566-1EAF-4A29-92AE-9AF4A8476A14

P356

Q57181194-015D816B-8EB6-440E-82A4-C231D7741FAB

P407

Q57181194-5821AFF6-5E1D-4C7B-8CB4-40F265C77243

P433

Q57181194-97108985-005B-4907-A195-EDA1E0D3E4C9

P478

Q57181194-5148B1DA-A7E3-4475-9B1A-B35BD2713ED5

P50

Q57181194-6DF8D69B-FC0D-4BA0-B903-4F8EB3751E89

P577

Q57181194-949650E3-6E61-4B39-A569-0BD59D06E250

P698

Q57181194-38919DCA-3F9A-4B2F-A450-45E8F7F38B42

P356

P1433

The Journal of Infectious Diseases

P1476

Factors influencing increases ...... active antiretroviral therapy

@en

P2093

Andrew N Phillips

http://www.w3.org/2001/XMLSchema#string

Colette J Smith

http://www.w3.org/2001/XMLSchema#string

Fiona C Lampe

http://www.w3.org/2001/XMLSchema#string

Ian Cropley

http://www.w3.org/2001/XMLSchema#string

Margaret A Johnson

http://www.w3.org/2001/XMLSchema#string

Mike S Youle

http://www.w3.org/2001/XMLSchema#string

Sabine Kinloch-de Loes

http://www.w3.org/2001/XMLSchema#string

Sara Madge

http://www.w3.org/2001/XMLSchema#string

P304

1860-1868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/425075

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-10-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15499544

http://www.w3.org/2001/XMLSchema#string